Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Validation of Compression Process for Tablets

Posted on By

SOP for Validation of Compression Process for Tablets

Standard Operating Procedure for Validating Compression Process for Tablets

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the validation procedure for the tablet compression process. This SOP ensures that the tablet compression process consistently produces tablets that meet the required quality specifications, including uniformity, hardness, disintegration, and weight. By validating critical parameters such as compression force, tablet weight, and tablet hardness, this SOP ensures that the compression process operates within specified limits, guaranteeing batch-to-batch consistency and compliance with regulatory standards.

2) Scope

This SOP applies to the tablet compression process used in the manufacturing of all tablet forms within the facility. It covers the process validation activities for both new tablet formulations and existing formulations undergoing significant process changes. This SOP ensures that the critical parameters in the compression process are validated for consistency and compliance with quality standards. It applies to all stages of tablet compression, from material feeding to tablet ejection. The SOP is intended for use by quality assurance (QA), production teams, and technical personnel involved in tablet compression.

3) Responsibilities

Operators: Responsible for carrying out the tablet compression process according to the approved protocol and ensuring that all

critical process parameters are followed and documented.
Quality Assurance (QA): Ensures that the compression process is validated in compliance with this SOP and regulatory requirements. QA is also responsible for reviewing and approving all validation documentation and reports.
Production Supervisors: Oversee the compression process and ensure that it is conducted according to the approved protocol, with operators following all required procedures.
Validation Team: Develops the tablet compression process validation protocol, executes the validation runs, and analyzes the results.
Maintenance Personnel: Ensures that the tablet compression equipment is properly calibrated, maintained, and functioning before and during the validation process.

See also  SOP for Process Validation of Sustained-Release Capsules

4) Procedure

The following steps should be followed for the validation of the tablet compression process:

1. Preparation for Validation:
1.1 Review batch records to identify critical process parameters (CPPs) for the tablet compression process, such as tablet weight, hardness, and friability.
1.2 Develop a process validation protocol, including objectives, scope, equipment, and personnel involved in the validation process.
1.3 Ensure that all tablet compression equipment, such as rotary tablet presses and single-station presses, are calibrated and operational before initiating the validation process.

2. Validation Protocol:
2.1 Protocol Design: The validation protocol should be designed based on the tablet formulation and the specific tablet compression equipment used.
2.2 Defining Acceptance Criteria: Establish acceptance criteria for critical parameters such as tablet weight uniformity, hardness, friability, disintegration, and dissolution rate. The criteria should also include parameters such as compression force and speed.
2.3 Risk Assessment: Perform a risk assessment to identify critical quality attributes (CQAs) and corresponding critical process parameters (CPPs). This helps identify potential risks to tablet quality and establish mitigation strategies.

3. Execution of Validation:
3.1 Tablet Feeding: Validate the feeding process to ensure the correct amount of powder is consistently fed into the tablet press, ensuring uniformity in tablet weight.
3.2 Compression Force: Validate the compression force applied to the powder mixture. Ensure that the applied force produces tablets with the correct hardness while avoiding over-compression or under-compression.
3.3 Tablet Ejection: Ensure that the tablet ejection process does not cause damage to the tablets, such as chipping or cracking.
3.4 Tablet Hardness and Weight: Validate the tablet hardness and weight to ensure they meet the predefined specifications. Perform sampling at various time intervals to assess consistency.
3.5 Tablet Friability: Validate the friability of the tablets to ensure they are not overly brittle or prone to breakage.
3.6 Tablet Disintegration: Validate the disintegration time of the tablets to ensure they meet the specified disintegration criteria.
3.7 Tablet Dissolution: Conduct dissolution testing to ensure that the tablets release the active pharmaceutical ingredient (API) within the required time frame and that the release rate is consistent with the product specifications.

See also  SOP for Process Validation of Ophthalmic Preparations

4. Documentation and Reporting:
4.1 Record all data during the validation process, including batch records, equipment logs, process parameters, and testing results.
4.2 Ensure that all forms, reports, and certificates are completed and signed by the responsible personnel.
4.3 Perform statistical analysis of the collected data to assess process consistency and capability. The analysis should confirm that the process is capable of producing tablets that meet all quality specifications.
4.4 Prepare a final validation report summarizing the results, including any deviations from the acceptance criteria and corrective actions taken, if necessary.

5. Revalidation:
5.1 Revalidate the compression process if there are significant changes to the formulation, equipment, or critical process parameters.
5.2 Periodically conduct revalidation to ensure continued compliance with regulatory requirements and confirm that the compression process remains capable of producing tablets that meet quality specifications.

See also  SOP for IQ/OQ/PQ of Homogenizers for Creams and Ointments

5) Abbreviations

  • QA: Quality Assurance
  • CPP: Critical Process Parameter
  • CQA: Critical Quality Attribute
  • SOP: Standard Operating Procedure

6) Documents

  • Process Validation Protocol
  • Batch Production Records
  • Equipment Calibration Logs
  • Process Validation Reports
  • Raw Material Certificates of Analysis
  • Statistical Analysis Data

7) Reference

  • International Council for Harmonisation (ICH) Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Process Validation
  • ISO 9001: Quality Management Systems – Requirements

8) SOP Version

Version 1.0 – Effective Date: DD/MM/YYYY

Annexure

Template 1: Compression Process Record

Date Time Operator Initials Compression Force Tablet Weight
DD/MM/YYYY HH:MM Operator Name Force in kN Weight in mg
         

Template 2: Tablet Hardness Record

Batch No. Tablet Hardness Test Date Operator Initials
Batch Number Hardness in N DD/MM/YYYY Operator Name
       

Template 3: Tablet Disintegration Test Record

Batch No. Test Date Disintegration Time Operator Initials
Batch Number DD/MM/YYYY Time in minutes Operator Name
       

Template 4: Tablet Friability Record

Batch No. Test Date Friability (%) Operator Initials
Batch Number DD/MM/YYYY Friability in % Operator Name
       

Template 5: Statistical Analysis Data

Sample ID Test Type Mean Standard Deviation Result
Sample Number Test Name Mean Value Standard Deviation Pass/Fail
         
Validations and Qualifications Tags:Cleaning Validation in Pharmaceutical Industry, Computer System Validation in Pharma, Computer System Validation in Pharmaceuticals, Define Validation in Pharma, Equipment Qualification in Pharma, Method Validation in Pharma, Performance Qualification in Pharma, Pharma Validation, Pharmaceutical Cleaning Validation, Pharmaceutical Method Validation, Pharmaceutical Process Validation, Pharmaceutical Process Validation SOP, Pharmaceutical Validation Definition, Pharmaceutical Validation Services, Process Validation Definition in Pharma, Process Validation in Pharma, Process Validation in Pharma Industry, Process Validation in Pharmaceutical Industry, Prospective Validation in Pharma, Qualification in Pharma, Software Validation in Pharmaceutical Industry, SOP for Analytical Method Validations, SOP for Cleaning Validations, SOP for Equipment Validations, SOP for Process Validation, SOP for Validations, Types of Validation in Pharma, Types of Validation in Pharmaceutical Industry, Validation in Pharmaceutical Industry, Validation Life Cycle in Pharma

Post navigation

Previous Post: SOP for Validation of Blending Process for Powders
Next Post: SOP for Cleaning of Nebulizer Air Handling Units

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version